vindesine has been researched along with Liver Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraoka, N; Ichikawa, H; Imai, T; Ishigamori, R; Nara, S; Takahashi, M; Yonemaru, J | 1 |
| Chen, H; Liang, J; Luo, L; Ma, R; Shi, C; Ye, W; Zhang, D | 1 |
| Eigentler, TK; Garbe, C | 1 |
| Andersen, PK; Dombernowsky, P; Nielsen, D; Osterlind, K; Ryberg, M; Skovsgaard, T | 1 |
| Brunner, KW; Goldhirsch, A; Joss, RA | 1 |
| Rodier, J; Timbal, Y | 1 |
| Aoki, K; Ikeda, K; Ishida, K; Iwaya, T; Kimura, Y; Koeda, K; Ogasawara, S; Ohtsuka, K; Saito, K; Sato, N | 1 |
| Calista, D; Landi, C; Schianchi, S | 1 |
| Green, JA; Iqbal, M; Marshall, E | 1 |
| Delsol, G; Farcet, JP; Gaulard, P; Martin-Garcia, N; Mempel, M; Rigal-Huguet, F; Suarez, F; Wlodarska, I | 1 |
| Charlotte, F; Godeau, P; Leblond, V; Piette, JC; Sbaï, A; Wechsler, B | 1 |
| Ando, N; Ida, H; Iizuka, T; Kakegawa, T; Takagi, I; Watanabe, H | 1 |
| Chapman, D; Fiore, J; Kambhu, SA; Kelsen, DP; Niedzwiecki, D; Rosenbluth, R; Vinciguerra, V | 1 |
| Ando, N; Ide, H; Ishida, K; Kakegawa, T; Lizuka, T; Mori, S; Nashimoto, A; Sasaki, K; Takagi, I; Watanabe, H | 1 |
2 review(s) available for vindesine and Liver Neoplasms
| Article | Year |
|---|---|
[Therapy of malignant melanoma at the stage of distant metastasis].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Disease Progression; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Skin Neoplasms; Temozolomide; Time Factors; Tomography, X-Ray Computed; Vindesine | 2004 |
[Treatment of patients with recurrent esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Prognosis; Survival Rate; Vindesine | 1998 |
2 trial(s) available for vindesine and Liver Neoplasms
| Article | Year |
|---|---|
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Epirubicin; Female; Humans; Incidence; L-Lactate Dehydrogenase; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Prognosis; Prospective Studies; Receptors, Estrogen; Risk Factors; Vindesine | 2005 |
Phase II evaluation of combined cisplatin and vindesine in advanced squamous cell carcinoma of the esophagus: Japanese Esophageal Oncology Group Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Liver Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Vindesine | 1991 |
10 other study(ies) available for vindesine and Liver Neoplasms
| Article | Year |
|---|---|
A yolk sac tumor of the pancreas and derived xenograft model effectively responded to VIP chemotherapy.
Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; Diagnosis, Differential; Endodermal Sinus Tumor; Female; Humans; Ifosfamide; Liver Neoplasms; Mice; Pancreatic Neoplasms; Vindesine; Xenograft Model Antitumor Assays | 2020 |
Detection of Hyperacute Reactions of Desacetylvinblastine Monohydrazide in a Xenograft Model Using Intravoxel Incoherent Motion DWI and R2* Mapping.
Topics: Animals; Capillary Permeability; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Feasibility Studies; Female; Heterografts; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Mice; Mice, Inbred BALB C; Microcirculation; Tumor Cells, Cultured; Vindesine | 2019 |
Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
Topics: Altretamine; Antineoplastic Agents; Carcinoma, Small Cell; Drug Therapy, Combination; Humans; Leukocyte Count; Liver Neoplasms; Lung Neoplasms; Male; Mitomycins; Vinblastine; Vindesine | 1982 |
[Apropos of a case of renal oncocytoma with hepatic localization].
Topics: Adenoma; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Triethylenemelamine; Vinblastine; Vindesine | 1984 |
Malignant blue nevus of the scalp.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Fatal Outcome; Humans; Interferon-alpha; Liver Neoplasms; Lung Neoplasms; Nevus, Blue; Scalp; Skin Neoplasms; Vindesine | 1998 |
Ten-year survival in advanced malignant melanoma following treatment with interferon and vindesine.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Humans; Interferon-alpha; Liver Neoplasms; Male; Melanoma; Skin Neoplasms; Vindesine | 2000 |
Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 7; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Fatal Outcome; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Isochromosomes; Liver Neoplasms; Lymphoma, T-Cell; Male; Prednisone; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Splenic Neoplasms; T-Lymphocytes; Vindesine | 2000 |
[Multinodular hepatopathy].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Sex Factors; Time Factors; Ultrasonography; Vindesine | 2002 |
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasms, Unknown Primary; Prognosis; Remission Induction; Survival Rate; Vindesine | 1990 |
A phase II study of vindesine in the treatment of esophageal carcinoma. Japanese Esophageal Oncology Group.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Remission Induction; Vindesine | 1989 |